Reaction
Dyspareunia reporting signals
As of the last recalculation, Dyspareunia appears in 4,530 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is COPPER (PRR 147.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Copper | 1,064 | 147.9 | 151.7 |
| Levonorgestrel | 1,978 | 79.3 | 80.1 |
| Etonogestrel And Ethinyl Estradiol | 114 | 24.2 | 24.3 |
| Estradiol | 121 | 6.6 | 6.6 |
| Medroxyprogesterone Acetate | 65 | 6.1 | 6.1 |
| Etonogestrel | 58 | 5.6 | 5.6 |
| Conjugated Estrogens | 69 | 5.5 | 5.5 |
| Estrogens, Conjugated | 69 | 5.4 | 5.4 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 37 | 4.8 | 4.9 |
| Misoprostol | 10 | 4.7 | 4.7 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 38 | 4.2 | 4.2 |
| Leuprolide Acetate | 70 | 4.2 | 4.2 |
| Estradiol Gel 0.1% | 40 | 4.1 | 4.1 |
| Estradiol Transdermal | 40 | 4.1 | 4.1 |
| Cyclobenzaprine Hydrochloride | 7 | 3.6 | 3.6 |
| Ibuprofen And Diphenhydramine Citrate | 18 | 3.6 | 3.6 |
| Drospirenone And Ethinyl Estradiol | 34 | 3.6 | 3.6 |
| Progesterone | 17 | 3.4 | 3.4 |
| Thyroid, Porcine | 7 | 3.0 | 3.0 |
| Bupropion Hydrochloride | 61 | 2.9 | 2.9 |
| Nevirapine | 5 | 2.5 | 2.5 |
| Abemaciclib | 9 | 2.1 | 2.1 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 10 | 1.9 | 1.9 |
| Isotretinoin | 14 | 1.3 | 1.3 |
| Adapalene | 4 | 0.1 | 0.1 |